ARTICLE | Company News
Savara, Cystic Fibrosis Foundation infectious, drug delivery news
October 28, 2013 7:00 AM UTC
Savara received a $1.7 million research award from Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the drug development affiliate of the not-for-profit foundation, to develop AeroVanc. The produ...